CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells

CTLA4Ig has been successfully used in the clinic for suppression of T cell activation. However, patients treated with CTLA4Ig experienced reduced incidence of tumors than predicted, but the underlying mechanism remains unknown. In this paper, we showed that brief administration of CTLA4Ig significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yanmeng, Luo, Gaoxing, Zhou, Junyi, Wang, Xiaojuan, Hu, Jie, Cui, Yanyan, Li, Xian C., Tan, Jianglin, Yang, Sisi, Zhan, Rixing, Yang, Junjie, He, Weifeng, Wu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859666/
https://www.ncbi.nlm.nih.gov/pubmed/24349559
http://dx.doi.org/10.1371/journal.pone.0083913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859666/
https://www.ncbi.nlm.nih.gov/pubmed/24349559
http://dx.doi.org/10.1371/journal.pone.0083913

Ejemplares similares